ALTEN Calsoft Labs, a leader in healthcare IT services has been at the forefront in harnessing digital technology to provide quality patient care and accelerating innovation around value based healthcare IT solutions delivery models. As a leading healthcare IT company, we are committed to provide best of the breed solutions that improve the health and wellness of members, patients, colleagues and communities. For more information, call Nick Spring at 408-771-7285 or

Apprentice helps life science manufacturers get treatments to patients faster by providing one platform to turn molecules into medicine. Our Tempo Manufacturing Cloud lets you scale up and out with unprecedented speed and accuracy. From preclinical benchtop to large-scale commercial manufacturing, Tempo keeps your global teams connected, empowered, and in sync.

With $140M in funding, a 12x growth rate, and 512% net customer retention, Apprentice is a trusted partner to modernize your operations and change the way drugs are made in your facility. Learn how leading companies like Catalent, Synthego, and Bristol Myers Squibb are using Tempo to scale from drug discovery to patient delivery faster at


Essenlix, a digital health and wellness company, provides a game-changing instant mobile health self-test platform, iMOST, that allows any person to accurately perform a diagnostic/health test her/himself, anywhere, anytime, using a single drop of body fluid and a smartphone, all within 60 seconds, at a low cost, with the result sent immediately to professionals. iMOST™ (Instant Mobile Self-Test), first of the type, is based on out of-the-box thinking and a fundamentally different paradigm that is realized through uniquely implementing nanotechnology, advance imaging, and artificial intelligence/machine learning into diagnostic testing. iMOST delivers clinical lab-quality test results using a simple device, even when a sample, device, process, and operation are imperfect. Diagnostic lab-testing is a vital and necessary procedure for diagnosing diseases and monitoring health conditions. The iMOST platform is removing one of the largest barriers in digital health by replacing a conventional inconvenient, time consuming, and expensive lab-test with an instant mobile self-test platform. Essenlix aims to make iMOST available to most of the world’s 7 billion population.  For more information, please contact Theresa Jenkins at or 732-274-1020.

Health Interactive (HI) is a digital health company providing bioinformatics data analysis. HI provides bioinformatics analytical services for genetic testing, pharmacogenomic analysis, inherited disorders including cancers, cancer gene mutations, and other genomic analyses. Learn more.

IBM is the global leader in business transformation through an open hybrid cloud platform and AI, serving clients in more than 170 countries around the world. Today 47 of the Fortune 50 Companies rely on the IBM Cloud to run their business, and IBM Watson enterprise AI is hard at work in more than 30,000 engagements. IBM is also one of the world’s most vital corporate research organizations, with 28 consecutive years of patent leadership. IBM is engaged in digitizing healthcare across the care continuum, with passionate IBMers supporting Federal and State Governments, Life Sciences innovators, providers, payers and not-for-profits in improving the health of our nation. Above all, guided by principles for trust and transparency and support for a more inclusive society, IBM is committed to being a responsible technology innovator and a force for good in the world.  Learn more

Incedo, a Digital Transformation consulting, analytics and technology services company, works with leading Life Sciences and Healthcare companies to deliver transformative and innovative solutions leveraging Data, AI, and Cloud across clinical and commercial value chains. Incedo helps our customers achieve a sustainable business advantage by bridging the gap between business and technology bringing together strong engineering, data science and design capabilities with deep domain understanding. Incedo blurs the boundaries between services and products to maximize business impact from emerging technologies. For more information, visit  Learn More

Innoplexus uses proprietary, cutting edge technology to provide AI, machine learning and blockchain applications at every step of the drug discovery process: from early discovery to late stage clinical development in the effort to bring life saving drugs to patients faster, and more economically. For more information, please contact Rita Kelley at or 201-257-1703.

MedifVu, LLC is a digital heath company.  Our patent-pending product, i-HealthAssist™, is a provider and consumer focused application for treatment decisions and monitoring, resulting in Real-World-Data.    Leveraging the Wearable Market, our solution:

  • Uses Augmented Intelligence to prioritize treatment options personalized for each patient,immediately eliminating Adverse Drug Reactions.
  • Monitors the patient’s treatment experience directly and via wearables personalized to the specific medication’s side effects & warnings and the patient’s medical history
  • Captures Real World Data on the experiences of multiple patients on multiple medications to inform researchers for new and better treatments.

We are completing our initial commercial product.

 For more information, please contact Eileen Morrissey at or 973-570-4784.

Modal Technology Corporation, a disruptive 3rd wave AI technology company, provides life science researchers a non-statistical AI training platform that guarantees an optimal, repeatable training solution in a single run; reducing data scientists time and effort to move from identification to clinicals and providing an explainable proof to the hypothesis. Collaborating with researchers, we develop customized AI solutions using these unique capabilities. Modal has successfully explained the relationship of biomarkers to the disease while reducing time and expense to move the science forward. For more information visit our website @ or call 612.408.1241

Talking Medicines, the world’s first Artificial Intelligence driven patient intelligence company designed to meet the needs of pharma for patient feedback. Through a combination of AI and industry expertise, Talking Medicines has developed the next generation data platform to bring social listening for pharmaceutical companies into the new age. Its platform PatientMetRx® is driven by AI models that use machine learning and natural language processing to provide science-based insights which cut through the noise from social platforms. By structuring and translating the patient’s voice into a Patient Confidence Score, Talking Medicines helps to drive more effective marketing by pharma and ultimately deliver better patient outcomes.  For more information, please visit

WhizAI is the first and only augmented analytics AI for the Life Science industry. It helps companies cut the bottom line, reduce long development cycles and IT dependency, accelerate time to market and grow the top line. How? WhizAI connects directly to your data sets, trains itself on company-specific nuance and answers any analytics question almost instantly. Anyone can use it: from business users to IT. And — because WhizAI is Life Science Specific — it already understands how you think and talk. WhizAI is the trusted partner of choice at the top global life sciences companies. Automating Life Sciences analytics through purpose-built AI. Fast, simple and contextual, everything analytics was supposed to be. Learn more at